NAUTILUS NEUROSCIENCES
Nautilus Neurosciences is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with relevant products and services that directly benefit those affected by neurological disorders. In the first half of 2010, Nautilus intends to launch a novel product, CAMBIA� (diclofenac potassium for oral solution). Nautilus is backed by Tailwind Capital, a leading private equity firm that invests in health care, business services and media/communications companies.
NAUTILUS NEUROSCIENCES
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
Bridgewater, New Jersey, United States
Country:
United States
Website Url:
http://www.nautilusneurosciences.com
Total Employee:
11+
Status:
Closed
Contact:
9083937890
Email Addresses:
[email protected]
Total Funding:
17.76 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Network Solutions DNS Liquid Web Postmark
Current Advisors List
Current Employees Featured
Founder
Investors List
Tailwind Capital
Tailwind Capital investment in Series A - Nautilus Neurosciences
Official Site Inspections
http://www.nautilusneurosciences.com
- Host name: 98.129.229.225
- IP address: 98.129.229.225
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
